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 Summary  
 
Midkine-a (Mdka) is a heparin-binding growth factor from zebrafish, which 
regulates the fish brain formation during embryogenesis. Its homologs in zebrafish, 
Midkine-b, and in human, named Midkine, have 58% and 68% amino acid identity 
with Mdka respectively, but show distinctively different expression and functional 
patterns from Mdka. In order to understand more about how this growth factor 
functions, and why similar molecules can function differently, we sought to 
investigate their structural and mechanistic characteristics.  
In this study, the solution structure of Mdka is solved based on the 
multi-dimensional NMR spectroscopy using a novel assignment method developed by 
our group, which shows that this method works as well for small proteins as larger 
ones. Mdka contains two domains, and each of them consists of three anti-parallel 
β-sheets, resembling that of human Midkine. The N domain backbone architectures of 
Mdka and human Midkine are essentially the same, but C domains have major 
differences, which could be the reason for the differential functions of the two 
proteins.  
Our results provide new insights into the functional mechanism of the Midkine 
family; and directions for future structural study of this protein include: 1) comparing 
the structures of Mdka and Mdkb to understand why they have different functions; 
and 2) mapping the heparin binding site of Mdka to identify the specific residues 
important for the function of the protein. 
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Chapter 1 Introduction 
 
1.1 Studies on Mdka and Mdkb of zebrafish: heparin binding growth factors  
1.1.1 Biological background of zebrafish embryonic and neural development  
Zebrafish Danio rerio is a common and useful model organism for studies of 
vertebrate development and gene function (Mayden et al., 2007), since zebrafish 
embryos are large, robust, and transparent, and have the properties of developing 
rapidly and externally to the mother, characteristics which all facilitate experimental 
manipulation and observation (Dahm, 2006). Like other vertebrates’ embryo 
development, zebrafish development consists of stages of fertilization, cleavage, 
gastrulation, organogenesis and hatching. During gastrulation, three germ layers are 
formed in the early embryo: endoderm, mesoderm and ectoderm, which develop into 
different groups of the tissues. Among them, the ectoderm layer is supposed to 
develop into future neural systems by neurulation.  
Neurulation begins with the signals emitted from one discrete stripe of 
mesoderm to the ectoderm instructing the cells of the ectodermal tissue to change 
shape (Fig1.1). This process is coordinated as a whole, where the cells migrate to 
form a neural tube. The neural tube is the embryo's precursor to the central nervous 
system, which comprises the brain and spinal cord. During its formation, cells at the 
edges of the dorsal midline will sort themselves out by sticking to the non-neural 
ectoderm or sticking with the neural ectoderm. The former would develop into the 
epidermal epithelium while the latter would become part of the neural tube 
epithelium.  
 1
 A  
Fig1.1 Process of neurulation. (Kristjan R. Jessen & Rhona Mirsky, 2005) 
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However, of unusual significance are some in-between cells that form a loose 
aggregate in the space when the two epitheliums separate. These are neural crest cells 
which quickly migrate during or shortly after neurulation. Following their migration 
the neural crest cells differentiate into a wide variety of cell types throughout the body 
(Bronner-Fraser, 1995). The junction between neural and non-neural ectoderm, also 
called neural plate border, also gives rise to another kind of cells called Rohon-Beard 
(RB) sensory neurons. Different from neural crest cells, RB sensory neurons do not 
migrate away from the neural tube upon its closure, but remain within the central 
nervous system instead, and eventually comprise bilateral stripes in the developing 
dorsal spinal cord (Roberts, 2000).  
In the neural tube, a signaling center called the roof plate is formed when the 
Bone morphogenetic protein (BMP) from the epidermis permeated in. Meanwhile, in 
the ventral floor of the neural tube, a floor plate is formed due to Sonic hedgehog 
(Shh) protein from the notochord. These two molecules form a double gradient by 
spreading through the neural tube, and the identity of neurons in the tube can be 
determined by the relative concentrations of the two factors (Fig1.2). Therefore, the 
two signaling centers, the floor plate and the roof plate, affect the cell differentiation 
according to the position in the neural tube, thus determine the pattern formation in 
the embryonic spinal cord.  
At the dorsal mesoderm, cells that adjacent to the notochord during vertebrate 
organogenesis form transient structures called somite, which define the segmental 
pattern of the embryo, and subsequently give rise to vertebrae and ribs, dermis of the 
back, and skeletal muscles of the back, body wall and limbs (Wikipedia).  
 
1.1.2 Characterization of Mdka and Mdkb of zebrafish  
 3
  
Fig1.2 Organization of the neural tube. Mdka regulates floor plate formation. 
(Schäfer et al., 2005; Schäfer et al., 2007, Squire et al., 2003).  
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Mdka and Mdkb are the two heparin binding growth factors in zebrafish, 
while in mammals there is only one mdk gene encoding one secreted heparin binding 
growth factor. Mdkb was identified using an expression-cloning screen for neural 
inducing factors (Winkler and Moon, 2001). Using Mdkb as a query, Mdka was 
identified from searching the EST database, showing only ~70% nucleotide identity 
with Mdkb, 68% amino acid identity, and 72% similarity with Mdkb (Winkler et al., 
2003). Both Mdka and Mdkb contain more basic residues than acid ones, being 
positive charged proteins with theoretic isoelectric point (PI) of 9.59 and 9.53 
respectively. Both proteins are soluble proteins according to the hydropathy profiles 
(Fig1.3 & Fig1.4). The N terminals of both proteins are highly hydrophobic and the 
first 23 amino acids of each protein are supposed to form a signal peptide. The rest of 
the amino acids are mainly hydrophilic although there are two short hydrophobic 
segments at the amino acid positions of 43-47 and 110-116 in Mdka (Fig1.3).  
Mdka shows higher sequence identity (58%) with human Midkine compared 
to Mdkb (51%). Sequence comparison between the zebrafish Midkines and homologs 
from other species revealed the presence of 10 conserved cysteine residues, two 
clusters of basic residues (cluster I and cluster II) that are important for heparin 
binding, and a highly conserved hinge region that separates the amino-and carboxy- 
terminal domains (Iwasaki et al., 1997; Winkler, 2003; Fig1.5). In all fish Midkines, a 
highly conserved Arg residue that is essential for binding of Midkine to its receptor 
PTPζ is also present (Maeda et al., 1999). Two glutamine residues that are important 
for the formation of covalently linked dimers by tissue-type 2 transglutaminases are 
conserved in zebrafish (Kojima et al., 1997).  
 







Fig1.3 Sequence of Mdka. (A) The nucleotide sequence of the Mdka cDNA and its 
deduced amino acid sequences. (B) Hydropathy profile of Mdka (Software from 







Fig1.4 Sequence of Mdkb. (A) The nucleotide sequence of the Mdkb cDNA and its 
deduced amino acid sequences. (B) Hydropathy profile of Mdkb (Software from 
ExPSAy, ProtScale).  
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 Fig1.5 Sequence alignment of MK family. (Chang et al., 2004)  cluster I a.a. for 
heparin binding; cluster II a.a. for heparin binding.  
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Winkler (2003) first reported the expression patterns and biological activities 
of Mdka and Mdkb, revealing their important roles in the early neural development of 
zebrafish. Both Mdka and Mdkb are expressed in very dynamic and regionally 
restricted patterns during embryogenesis. Spatially, Mdkb expression is restricted to 
the dorsal regions of the developing nervous system, but Mdka is strongly expressed 
in a broad area in the central neural tube. At the beginning, Mdka expression is found 
in the paraxial mesoderm, which indicates the role of Mdka in somite formation. At 
16-h post fertilization (hpf), Mdka expression is found in epithelialized somites and 
also in a very dynamic fashion in the head region and in the spinal cord. Its expression 
is excluded from dorsal neural tube and the floor plate, which is the ventral most 
structure in the neural tube. In addition to spatial differences, the onset of transcription 
also differs for both genes. Mdkb expression starts during early gastrulation, about 4 h 
prior to Mdka that is first detectable at 10 hpf. Onset of Mdka expression is at tailbud 
stage in two lateral clusters of cells of the paraxial mesoderm (Fig 1.2B).  
Since Mdka and Mdkb show an overall 68% amino acid identity and the 
heparin binding as well as the hinge region are highly conserved, it opens to the 
question whether these two proteins share similar activities. To answer this question, 
an over-expression approach was used, which was to ectopically express mdka and 
mdkb genes after microinjection of in vitro-synthesized RNA into early zebrafish 
embryos. The resulting embryonic development was significantly different. 
Over-expression of Mdka affected the formation of somites and neural tube (Winkler 
et al., 2003) while injection of mdkb RNA resulted in generally posteriorized embryos 
lacking head structures rostral to the mid-hindbrain boundary (Winkler and Moon, 
2001). Therefore, both secreted growth factors, although structurally related, show 
different functions, and it would be interesting to investigate the functions of each 
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protein and why such structurally related proteins would have functional divergence.  
Although the exact functional mechanisms are not known, Mdka is reported to be 
required for the formation of the medial floor plate (Schäfer et al., 2005). On the 
contrary, Mdkb is the downstream signaling factors of several pathways, most notably 
retinoic acid, although the processes are still unclear. Other possible pathways include 
FGF signaling pathway, Wnt signaling pathway, and BMP signaling pathway. In 
addition, Mdkb controls the cell determination at the neural plate border and affects 
the formation of neural crest cells and Rohon-Beard sensory neurons (Liedtke et al., 
2008). As secreted growth factors, both proteins might bind to the transmembrane 
heparan sulfate proteoglycans. These receptors have the heparin-like carbohydrates; 
thus the growth factors for these kinds of receptors are classified as heparin-binding 
growth factors.  
 
1.1.4 Zebrafish PTN: another member of Mikine family in zebrafish  
Zebrafish heparin-binding neurotrophic factor (HBNF or PTN) is another 
secreted heparin-binding protein which is highly basic and contains ten cysteine 
residues (Chang et al., 2004). The amino acid sequence comparison shows that it 
displays 60% identity to human PTN, while only 39%-40% identity to human 
midkine, Mdka, and Mdkb (Fig1.5). During zebrafish embryogenesis, the expression 
of zebrafish PTN was observed upon fertilization and onwards. In adult fish, it is 
highly expressed in brain and intestine. The in vivo biological function of zebrafish 
PTN is found to promote neurite outgrowth.  
 
1.2 Structural and functional studies on Midkine and PTN of human  
1.2.1 Introduction  
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Midkine protein (MK) and Pleiotrophin (PTN; also called HB-GAM) are the 
two members of the MK family in human. Both proteins were discovered two decades 
ago (Kadomatsu et al., 1988; Rauvala, 1989), and have been studied extensively in 
vitro since then. As extracellular signaling molecules, MK and PTN play pivotal roles 
in neural development, pathogenesis of neurodegenerative diseases, and cancer 
development (Kadomatsu et al., 2004).   
 
1.2.2 Protein structures  
MK precursor protein with an intact signal peptide (22 amino acids) has a 
molecular mass of 15.6 kDa whereas the matured form of MK is calculated to be 13.2 
kDa. Mature PTN protein, which shares 45% amino acid sequence identity with MK 
(Fig1.6A), has a molecular weight of 19 kDa. The individual domain structures of 
MK have been solved by NMR (Iwasaki et al., 1997; Fig1.6B), and the NMR analysis 
has demonstrated that the three dimensional structures of MK and PTN are very 
similar (Kilpeläinen et al., 2000). Both proteins are essentially composed of two 
domains, the N-terminally located domain and the C-terminally located domain. 
These two domains are held by five disulfide bridges from ten conserved cysteine 
residues. Each domain contains three anti-parallel β-sheets. It is noteworthy that the 
heparin binding site of MK is mainly located in the C-domain which is responsible for 
most of the Midkine activities (Muramatsu et al., 1994 ), while that of PTN is equally 
distributed in both N- and C-domains (Kilpelainen et al., 2000). In the C domain of 
MK, two heparin binding clusters have been identified (Fig1.6B). Cluster I contains 
residues K79 (βC2), R81 (βC2), and K102 (βC3), all of which are located on the two 
β-sheets. All these three residues are conserved in the MK family from invertebrates 








N domain                             C domain  
Fig1.6 Human Midkine family sequence alignment and structure. (A) Sequence 
alignment of MK and PTN (Kadomatsu and Muramatsu, 2004). (B) NMR solution 
structure of human MK domains (Muramatsu, 2002).  
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βC3 form cluster II (Iwasaki et al., 1997; Fig1.6B). Upon binding to heparin ligand, 
MK could form a dimer, and this dimerization is important for the activity of MK. 
Three glutamine residues in human MK have been identified to be responsible for the 
transglutaminase-mediated dimerization (Kojima et al., 1997).  
 
1.2.3 Receptors of MK and PTN  
Heparin binding growth factors, like MK and PTN, could bind to a variety of 
transmembrane receptors on neurons and osteoblasts. Four kinds of receptors have 
been identified to have interactions with the MK family so far, including N-syndecan 
(Raulo et al., 1994; Mitsiadis et al., 1995; Kojima et al., 1996; Nakanishi et al., 1997), 
receptor-type protein tyrosine phophafase ζ (PTPζ) (Maeda et al., 1996; Maeda et al., 
1998; Maeda et al., 1999), anaplastic leukemia kinase (ALK) (Stoica et al., 2001; 
Stoica et al., 2002), and low density lipoprotein receptor-related protein (LRP) (Herz 
et al., 2000). N-syndecan belongs to the syndecan family that comprises four 
transmembrane heparan sulfate proteoglycans. Binding of MK and PTN to syndecans 
is mediated by the heparin sulfate chain, which is the heparin-like domain. This 
domain consists of a variably sulfated repeating disaccharide unit. PTPζ is 
transmembrane protein with chondroitin sulfate chains, where MK and PTN bind, and 
an intracellular tyrosine phosphatase domain. LRP and ALK can bind MK and PTN 
via extracellular potion of the receptor, but how exactly they interact is not clear. 
These receptors might be differentially utilized for specific biological activities such 
as neurite outgrowth (Li et al., 1990; Rauvala et al., 1994; Kaneda et al., 1996a), 
nerve cell migration (Maeda et al., 1998; Maeda et al., 1999), neurodegenerative 
diseases (Wisniewski et al., 1996; Yasuhara et al., 1993), and cancer (Kadomatsu et 
al., 2004). Many of the down-regulation pathways are still unclear, but it is pointed 
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out that the intracellular signaling of N-syndecan family receptors involves 
cortactin-src pathway, PTPζ and ALK receptors’ signaling pathways involve 
PI3-kinase and Erk, and the LRP receptor is responsible for the anti-apoptotic activity 
of MK.  
 
1.2.4 Biological activities  
MK and PTN are strongly expressed during embryogenesis, but their 
expression in adults are only restricted to kidney and tumors, and very low levels in 
brain (Kato et al., 2000; Mishima et al., 1997). Both MK and PTN have diverse 
biological functions, among which their roles in neural development and pathological 
aspects are of significant importance (Kadomatsu and Muramatsu, 2004). Both MK 
and PTN have been reported to be involved in the neurite outgrowth and nerve cell 
migration. MK also shows neuroprotective activity by preventing cell degeneration 
(Unoki et al., 1994). As to neurodegenerative diseases, both MK and PTN are 
reported to deposit at the senile plaques in Alzheimer’s patients. MK is also found at 
the neurofibrillary tangles in Alzheimer’s patients. Since MK and PTN can bind to 
LRP, and LRP has featured roles in Alzheimer’s disease, thus MK and PTN might be 
related to the pathogenesis of Alzheimer’s disease. Besides, MK knockout mice show 
that MK is involved in the pathogenesis of interstitial nephritis and vascular restenosis. 
The pathogenesis of both diseases might result from the recruitment of inflammatory 
cells by MK. But no receptors and signaling pathways have been discussed on this 
subject. Moreover, both MK and PTN are reported to be involved in cancer-related 
activities. For normal tissues of human adults, MK shows restricted expression, but 
for carcinoma specimens, MK expresses at a high level in a tissue type-independent 
manner, and its expression is more intensely and in a wider range of human 
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carcinomas than PTN. It is also reported that MK can promote cell growth, cell 
survival, and cell migration. And MK is shown to be highly expressed in all stages of 
neuroblastomas (malignant tumor that usually metastasizes quickly), and weakly in 
ganglioneuromas (benign tumors), while PTN expression can be high in both. 
Hitherto the exact signaling pathways involved in all these activities are still unknown, 
but it is possible that MK and PTN have different receptors or signal transduction 
pathways.  
 
1.2.5 Medical significance  
Since MK and PTN are closely involved in several diseases, especially cancer, 
their medical significances were proposed by Kadomatsu and Muramatsu (2004). One 
possible application is that they could be used as tumor markers, since there are 
elevated blood levels of both proteins in cancer patients, and the protein level would 
be decreased when the tumors are removed. Besides, the blood level of MK is 
significantly correlated with prognostic factors of neuroblastomas, while PTN level is 
reported to be correlated with the prognosis in pancreatic carcinoma patients. Another 
possible application is that they might be used as gene therapy targets since a suicide 
gene under the control of the mdk promoter is identified as a highly potential strategy 
for curing carcinomas. The third application is that they could be the molecular targets 
of therapy for carcinomas. Since both in vitro and in vivo assays using mice have 
demonstrated that antisense MK oligodeoxyribonucleotides suppressed cell growth, 
anchorage-independent growth, tumor growth of mouse colorectal carcinoma cells, 
and pre-grown tumors in nude mice via atelocollagen-mediated gene transfer; 
disruption of MK or its signaling pathway could be a strong means of curing human 
carcinomas. Similar situations applies to PTN, except that it is PTN-targeted 
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ribozymes (enzymatically active RNAs, i.e. ribozymes, that were designed to 
specifically cleave the PTN mRNA thus leading to significantly reduced PTN levels) 
that can suppress the growth of tumors, and a part of the N-terminal of PTN shows a 
dominant-negative form in the growth of human breast cancer cells. Therefore, PTN 
and its signaling molecules could also be a molecular targeting candidate for cancer 
therapy.  
 
1.3 Protein structure determination by NMR  
1.3.1 Introduction to NMR spectroscopy  
1.3.1.1 Development of NMR  
NMR development began in the area of physics in 1938 when Isidor Rabi 
(Nobel Prize 1944) firstly described and measured the resonance in molecular beams. 
Eight years later, Purcell et al., and Bloch independently refined the technique and 
reported the phenomenon of NMR, for which they shared the Noble Prize in Physics 
in 1952. In the 1940s and 1950s, many basic parameters and theories of NMR were 
discovered such as chemical shift, spin-spin coupling, spin relaxation, and Overhauser 
effect, which laid the foundation of NMR method development. In 1966, Fourier 
Transform (FT) techniques were introduced by Ernst, and later he developed the 
multi-dimensional NMR, thus began the era of FT NMR (Nobel Prize 1991). Its 
application in biological sciences was marked by Kurt Wüthrich when he developed 
the NMR spectroscopy for determining 3D structures of biological macromolecules in 
solution (Nobel Prize 2002). Today, with the accessibility of improved NMR 
hardware and better developed NMR methodology, NMR has gained wide application 
in the areas of chemistry, biology and medicine.  
In biological sciences, with the development of molecular biology and 
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biochemical methods for preparing and isolating isotope labeled biomolecules, NMR 
has become a powerful tool for biomolecule structure characterization, protein 
dynamics, and identification of bioactive compounds.  
 
1.3.1.2 Basic theories of NMR  
1.3.1.2.1 Chemical shift  
Neutrons and protons that composing an atomic nucleus have an intrinsic 
quantum mechanical property called spin. Spins within different chemical 
environments would have different resonance frequencies. This is because of the 
electrons that circulating about the direction of the applied external magnetic field. 
The circulation would cause a small magnetic field at the nucleus; thus the actual 
magnetic field at the nucleus is different from the applied one. As in an NMR 
spectrum, each nucleus gives rise to a resonance which is characterized by chemical 
shift reflecting its unique chemical environment. Chemical shift is an important 
parameter for identifying individual nucleus and assigning the resonances in the 
spectrum to their corresponding atoms in a molecule. Moreover, characteristic 
chemical shifts in an amino acid residue can be helpful for identifying individual 
residues in a protein sequence and determining protein secondary structure (Wishart et 
al., 1991). Chemical shift is measured in parts per million (ppm) in order that the 
value is independent of the static magnetic field strength.  
 
1.3.1.2.2 J coupling  
Scalar couplings or J-couplings are mediated through chemical bonds between 
two spins. The energy levels of each spin are slightly altered depending on the spin 
state of a scalar coupled spin (α or β). This gives rise to a splitting of the resonance 
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lines. Scalar couplings are used in multidimensional (2D, 3D, 4D) correlation 
experiments to transfer magnetization from one spin to another in order to identify 
spin systems, e.g. spins which are connected by not more than three chemical bonds 
(Sattler, 2004).  
 
1.3.1.2.3 NOE  
The nuclear Overhauser effect (NOE) is a result of cross-relaxation between 
dipolar coupled spins as a result of spin/spin interactions through space. The NOE 
allows to transfer magnetization from one spin to another through space, and scales 
with the distance r between the two spins (NOE ~ 1/r
6
), e.g. two protons in a protein. 
When interproton distances are larger than 5 Å, the NOE may be too small to be 
observed. Therefore NOEs are related to the three-dimensional structure of a molecule 
(Sattler, 2004).  
 
1.3.2 General strategies of protein structure determination by NMR  
1.3.2.1 Sample Preparation  
The protein sample for NMR experiments is often prepared by overexpressing 





N isotopes. About 0.5 ml protein solution with a 
concentration of ~1 mM protein is usually required in structure elucidation. Different 
buffer conditions (pH, salt concentrations, and types of buffer) need to be tested to 
optimize the quality of the NMR spectra and to avoid protein aggregation. Sometimes, 
the native protein needs to be modified, such as cutting the protein into separate 
domains, or making constructs with various sizes and domain boundaries, in order to 




 Sample preparation  









Distance and torsion angle constraints  




Structure calculation and refinement 




Evaluation of structure quality 
 
 




N isotopes, unlabeled sample can be used to determine if a protein sample 
prepared under a certain condition is folded or not using 1D 
1
H NMR experiment.  
 
1.3.2.2 Spectrum collection and Resonance Assignments  
A set of heteronuclear multidimensional NMR experiments and NOESY 
experiments (From 2D to 4D) are recorded for the assignment of the chemical shifts 
of all spins and NOE peaks. The total time for NMR data acquisition varies from ten 
days to four weeks depending on the experiments adopted. The chemical shift 
assignments of backbone and sidechain atoms are typically obtained from the 
triple-resonance experiments, which can be done manually or automatically. The 
chemical shifts alone would allow the determination of protein secondary structure. 
H-H NOE peaks observed in the NOESY spectrum can be used to assign the 
inter-atomic distances.  
 
1.3.2.3 Collection of NMR Restraints  
Besides the distance constraints derived from NOE, other structural 
information can be obtained for structure calculation. These include 
3
J-coupling 
constants that provide dihedral angles information, residual dipolar couplings that 
show information about bond projection angles, and solvent exchange that measures 







shifts with the program TALOS (Cornilescu et al., 1999).  
 
1.3.2.4 Structure Calculations and Refinement  
A restrained molecular dynamics/simulated annealing (MD/SA) or torsion 
angel dynamics (TAD) is chosen for structure calculation, which would use all the 
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available structural parameters mentioned above. Structure calculation with NOE 
assignment is an iterative process. The result of an NMR structure calculation is an 
ensemble of structures, all of which are consistent with the experimental NMR data. 
The calculated structures should converge to the same fold. Poor convergence may 
indicate problems of the experimental constraints and/or the MD/SA/TAD protocol 
(Sattler, 2004).  
 
1.3.2.5 Evaluation of protein NMR structure  
Factors for evaluation of protein NMR structures include the root-mean-square 
deviation (RMSD), Distance constraints violation, dihedral angle violation, 
electrostatic potential term, van der Waals force, and the Ramachandran plot. The 
RMSD indicates the coordinate precision of the structure ensembles calculated. The 
smaller the value of RMSD between the calculated conformers and the mean 
structures (usually less than 1 Å), the better the quality of the structures calculated. 
Distance constrains violation should be within 0.5 Å, while dihedral angle violation 
should be within 5°. As for the electrostatic potential term, negative results indicate 
good structure quality. Besides, the number of bad contacts, e.g. the number of 
restraints with too short atom-atom distances in a molecule should be small, otherwise 
the experimental constraints might be applied too strong and cause van der Waals 
clashes. Furthermore, the Ramachandran plot, which specifies the fraction of 
backbone φ,ψ angles which correspond to favored, additionally allowed, generally 
allowed and disallowed conformations based on statistical analysis of high-resolution 
crystal structures, is a good quality measure. Most φ,ψ angles should be within the 
allowed regions, while poor quality structures usually have a large number of φ,ψ 
angles in forbidden regions in the Ramachandran plot.  
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 1.3.3 Advantages of structure study by NMR  
Nuclear Magnetic Resonance, X-ray Crystallography, and Cryo-electron 
Microscopy are the only three methods to solve protein structures so far. Only Nuclear 
Magnetic Resonance and X-ray Crystallography can be used to solve high resolution 
structures of proteins, nuclear acids and their complexes. The uniqueness of NMR 
methods is that the samples are in solution. The pH, salt concentration and 
temperature can all be adjusted so that the biomoleucles’ physiological condition can 
be mimicked. Besides, NMR can be used to study the dynamics of biomoleucles, to 
investigate structural, thermodynamic and kinetic aspects of interactions between 
proteins and other solution components.  
 
1.4 Objectives of this project  
Mdka and Mdkb are new heparin binding growth factors found in zebrafish 
seven years ago, and many functions of the proteins are still unclear. These two 
proteins share high sequence identity, but perform different expression patterns and 
functions. On the one hand, Mdka, expressed in the paraxial mesoderm, is involved in 
the medial floor plate formation. On the other hand, the role of Mdkb is proposed to 
be specifying the formation of neural crest cells and Rohon-Beard sensory neuron by 
acting downstream of several signaling pathways at the neural plate border near the 
roof plate. Therefore it is interesting to understand why two growth factors with high 
sequence similarity would have different functions in the embryogenesis of zebrafish.  
In this study, the structure of Mdka is characterized. The major objective of this study 
is to elucidate the structural information of this protein, and compare the structure of 
Mdka with those of other homologs to understand the functional prosperities of Mdka. 
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The structural study of Mdka would lay foundation for the functional study of this 
protein family, such as the binding properties of the protein with heparin ligand and 
receptors. By comparing the structures of Mdka and Mdkb, we might gain new 
insights into the functions of the two proteins.  
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Chapter 2 Materials and Methods 
 
2.1 NMR sample preparation  
2.1.1 Media  
LB Broth: 1 L culture contains 10 g tryptone, 5 g of yeast extract, and 10 g of NaCl 
and 100 μg/ml ampicilin  
LB Agar: 1 L culture contains 10 g tryptone, 5 g yeast extract, 10 g NaCl, 15 g agar 
and 100 μg/ml ampicilin  
M9 minimal medium: 1 L culture contains 1 g NH4Cl, 2 g Glucose, 0.0147 g 
CaCl2(H2O), 0.493 g MgSO4(7H2O), 7.52 g Na2HPO4, 3 g KH2PO4, 0.5 g NaCl 
and 100 μg/ml ampicilin  
 
2.1.2 Preparation of DNA plasmid  
The gene encoding Mdka protein was obtained from our collaborator, Prof 
Winkler (Dept. of Biological Sciences, NUS), in the template plasmid pCS2 Zmk-2. 
Oligonucleotide primers were used to amplify the mdka gene. The sense primer is 
5’-CGCGGATCCAAAAACAAGAAAGAGAAGAA-3’ and antisense primer is 
3’-GGGGATATCACTCAGCATAAT-5’. DNA gel electrophoresis (Agarose from 
Bio-Rad) was subsequently performed to separate the template plasmid from the 
desired PCR products. The recovered PCR products were digested with BamHI and 
XholI restriction enzymes (New England Biolabs). After purification using the 
QIAquick Gel Extraction Kit 250 (QIAGEN), the mdka DNA fractions were ligated to 
the pGEX-4T-1 vector, which has a GST tag. The obtained Plasmids were sequenced 
(reaction Kit from Perkin Elmer) using the automated DNA sequencer for verification.  
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2.1.3 Transformation of E .coli competent cells  
The mdka plasmids were transformed into E. coli BL21 (DE3) competent cells 
and were spread onto LB agar plates containing the ampicilin antibiotic selective for 
the plasmid. The plates were incubated for 12~16 hours at 37 °C to enlarge the 
bacterial colony.  
 
2.1.4 Protein expression and purification  
2.1.4.1 Expression of unlabeled Mdka  
The construct containing the mdka gene was expressed in the E. coli Strain 
BL21 (DE3) using LB medium. Procedure begins with inoculating one single colony 
containing mdka plasmid in 5 ml LB culture with 100 μg/ml ampicilin at 37 °C 
shaking overnight at 200 rmp. Then the overnight culture was transferred to 1 L fresh 
LB broth to inoculate at the same condition until the OD600 was around 0.4. To have 
an expression control, 1 ml of the culture was taken out, centrifuged, and the pellet 
was re-suspended with 50 μl SDS-PAGE sample buffer. The rest of the culture was 
induced with 0.05 mM IPTG at 16 °C for 12 hours. 1 ml of the induced culture was 
taken out, centrifuged, and the pellet was re-suspended with 50 μl SDS-PAGE sample 
buffer to test the protein expression level. The rest of the culture was centrifuged and 
pellets were collected for protein purification.  
 
2.1.4.2 Expression of labeled Mdka  
The expression protocol was quite similar as that of unlabeled Mdka except 
that the culture used was M9 medium. The culture used for 
15
N labeled Mdka was M9 
medium with 
15




C labeled Mdka was medium 
with 
15
N labeled NH4Cl and 
13
C labeled glucose. After the cell density reached 
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OD600 around 0.6, 0.3 mM IPTG was added to induce protein expression at 20 °C for 
20 hours.  
 
2.1.4.3 Purification of Mdka  
The cell pellets collected by centrifuge were re-suspended with lysis buffer (20 
mM Tris buffer, pH 8.0, 150 mM NaCl). After sonication thoroughly, the cell lysate 
was centrifuged to remove the unsonicated pellets. The supernatant was mixed with 
GST beads which have been wash with water and equilibrated with lysis buffer. The 
mixture was shaken at 4 °C for one hour followed by separating the resin from the 
flow-through. The resin was washed with lysis buffer four times to wash out the 
unspecific bindings. Then 10 U thrombin was added to the resin with 5 ml thrombin 
cleavage buffer (20 mM Tris buffer, pH 8.0, 150 mM NaCl, 2.5 mM CaCl2) to cleave 
GST tag from Mdka protein. Finally, the untagged protein was eluted with lysis 
buffer.   
After GST beads purification, there were still a few impurities. Therefore, 
heparin affinity column (HiTrap Heparin HP Column, GE Healthcare) was used with 
linear elution to further purify Mdka. The starting buffer was 20 mM Tris buffer, pH 
8.0, 150 mM NaCl, 2 mM EDTA, while the elution buffer was 20 mM Tris buffer, pH 
8.0, 2 M NaCl, 2 mM EDTA. The peak fractions collected from the FPLC machine 
were combined and concentrated for further protein assays.  
 
2.1.5 General protein assays  
2.1.5.1 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)  
12% and 15% SDS-PAGE were used to analyze the protein samples in 1 × 
sample buffer with electrophoresis apparatus (Bio-Rad). The 5 × sample buffer used 
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was 0.2 M Tris-HCl, pH 6.8, 25% (v/v) glycerol, 25% (v/v) SDS, 12.5% (v/v) 
2-mercaptoethanol, 0.005% (w/v) bromophenol blue. The running buffer was 25 mM 
Tris, 192 mM glycine and 0.1% (v/v) SDS. After mixing the protein sample with the 
sample buffer, the mixture was heated for 5 min before loading into the well of the 
SDS-PAGE. When the gel finished running, coomassie-blue solution [0.05% (w/v) 
Coomassie brilliant blue R, 25% (v/v) isopropanol, 10% (v/v) acetic acid] was used to 
stain the gel for 30 min followed by distaining with 10% acetic acid.  
 
2.1.5.2 Protein quantitative assay  
The protein concentration could be determined by UV absorbance at 280 nm, 
which was convenient and fast to use. The concentrated protein was diluted so that the 
UV absorbance was between 0.1 and 1.0 to ensure accuracy of the method. The 
concentration of the protein was calculated by the equation: A = εIC, where A stands 
for absorbance of UV, ε is the molar absorption coefficient (M-1cm-1), I denotes the 
path length (cm), and C is the protein concentration (M). The value of ε can be 
estimated using the ProtParam in the ExPASy Proteomics Server.  
 
2.1.5.3 Protein circular dichroism (CD)  
Far UV Circular Dichroism Spectroscopy was used to evaluate the secondary 
structure of Mdka. Experiments were carried out on a Jasco-810 spectropolarimeter 
(Jasco International Co. Ltd.) with a 0.1 nm quartz cuvette with a minimal sample 
volume of 250 μl. The protein sample was prepared by dialyzing against 10 mM 
phosphate buffer, and the protein concentration was within the range of 10~100 μM. 
The result was the average of 10 scans so that the background noise could be reduced.  
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2.1.5.4 Protein dynamic light scattering (DLS)  
To see if Mdka was still in the monomer form when the protein concentration 
was as high as 1 mM, Dynamic Light Scattering (Protein Solutions Inc) was used to 
evaluate the molecular weight of the protein particle. The protein sample was 
centrifuged at 15,000×g for 30 min at 4 ºC before adding the sample into a cuvette. 
The experiment was carried out at 30 ºC with 1 mM Mdka in the same buffer as the 
final NMR sample (20 mM phosphate buffer, pH 6.5, 100 mM NaCl, 2 mM EDTA). 
The maximal acquisition time was 10 sec and the data were analyzed using Dynamics 
5.0 software (Moradian-Oldak et al., 1998), where the standard curve of globular 
protein was selected for MW model.  
 
2.2 NMR experiments  
Bruker Avance 500 MHz and 800 MHz spectrometer equipped with pulse field 
gradient units and actively shielded cryoprobes were used to perform NMR 
experiments. Software used to process and analyze NMR data involved NMRPipe 
software (Delaglio et al., 1995) and NMRView (Johnson, 2004) on Linux 
workstations. A homemade NMRview plug-in was installed to assist the 4D NOE 








C HSQC, 3D HNCA, 
3D HNCOCA, 3D CCH-TOCSY, and 4D time shared NOESY experiments were used 
to do backbone, side-chain, and NOE assignments (Xu et al., 2006).  
 
2.2.1 1D NMR experiment  
1D NMR experiments were used to test whether the protein was folded 
properly in in-vitro condition so that the following NMR experiments could be 
performed. Unlabeled Mdka sample was used to acquire data at 20 ºC in H2O 
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(10%D2O) eluted using 20 mM Tris buffer, 100 mM NaCl, 2 mM EDTA at pH 8.0, 











N HSQC experiment was used to show the dispersion of Mdka 
backbone amide signals, from which we could tell whether the protein was in 







N labeled samples were used to record the experiments on the 800 











C HSQC experiment with aliphatic C-H correlation information 




N labeled sample was used to record the experiments on the 800 Hz NMR at 30 ºC.  
 
2.2.4 H/D exchange experiment  
Hydrogen bond restraints were obtained by observing the presence of any 
hydrogen-bonded amide proton peaks in the HSQC spectrum. These amide protons 




N HSQC spectrum was 
recorded within 20 min after changing the sample buffer to D2O buffer.  
 
2.2.5 3D HNCA and 3D HNCOCA experiments  
An HNCA experiment, which is often used in tandem with an HNCOCA 
experiment, can provide linkage information for the adjacent residues in a protein 
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sequence. In HNCA experiment, the magnetization of the amide proton of an amino 
acid residue is transferred to the amide nitrogen, and then to the alpha carbons of both 
the starting residue and the preceding residue in the protein's amino acid sequence. In 
contrast, the complementary HNCOCA experiment transfers magnetization only to 




N labeled sample 
was used to record the experiments on the 800 Hz NMR at 30 ºC.  
 
2.2.6 3D MQ-CCH-TOCSY experiment  
Like the traditional 3D HCCH-TOCSY experiment, the 3D MQ-CCH-TOCSY 
can correlate the sidechain aliphatic protons with the carbon spins in the same residue. 





sample was used to record the experiment on the 800 Hz NMR at 30 ºC.  
 
2.2.7 4D time shared NOESY experiment  
A time-shared 4D NOESY experiment (Xu et al., 2007) that records HN-HN 
NOE, HN-HC NOE, HC-HN NOE, and HC-HC NOE was used, which greatly 
reduced the time needed for data collection. The time-shared 4D NOESY spectrum 


















sample was used to record the 4D NOESY on the 500 Hz NMR at 30 ºC.  
 
2.3 Data processing  
NMR data were processed with NMRPipe, and NMRDraw was used to phase 
the spectra. All processed spectra were converted to the NMRView format for further 
analysis by NMRView.  
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 2.4 Resonance assignment  
2.4.1 Backbone assignment  
Peak picking of all NMR spectra was performed using the automatic function 












N chemical shifts with tolerances of 0.02 ppm for HN from intralist and interlist, 0.2 
ppm for nitrogen chemical shifts and 0.3 ppm for carbon chemical shifts. Chemical 





Each cluster usually contains one HNCA peak of residual i, its preceding residual i-1, 
and a few HC-HN NOE peaks. Among these NOE peaks, those belonging to residual i 
and i-1 could be identified and differentiated from long range NOE peaks by 
comparing the TOCSY slices defined by the (H, C) chemical shifts of each NOE peak. 
Those NOE peaks that have matched C
α 
chemical shifts with the HNCA and 
HNCOCA of residual i belong to the intra-residual and sequential NOEs. Since C
α 
chemical shifts alone can be ambiguous for assignment, MQ-CCH-TOCSY that 
provides sidechain chemical shift is used together to confirm assignment. Spin-system 
classification by residue type was done according to the chemical shifts of the spins in 





 chemical shifts, which were unambiguously recognized. 
Val and Leu were easily classified based on their characteristic sidechain chemical 
shifts, and Arg, Lys and Pro were also distinguished according to sidechain chemical 
shifts. The spin-systems were linked to build fragments when each two have identical 
C
α
 chemical shifts, the largest number of matched NOE peaks and no inconsistent (C, 
 31
H) chemical shifts. Finally, fragments containing the characteristic residues can be 
mapped onto the amino acid sequence of the Mdka by matching the positions of those 
characteristic residues. A general protocol for backbone sequential assignment is 
available online at http://www.natureprotocols.com/2006/11/09/noesybased_strategy_ 
for_assign.php.  
 
2.4.2 Sidechain assignment  
Most of the sidechain assignments were already done when doing backbone 




N-edited NOESY subspectrum. Some sidechain chemical shifts were assigned 
based on the NOE peaks of two adjacent spin-systems. The 3D MQ-CCH-TOCSY 








C-edited NOESY sub-spectra to perform or confirm the assignments.  
 
2.4.3 NOE assignment, structure calculation and refinement  













C-edited NOESY sub-spectra were assigned when a relatively complete 
chemical shift list was available. NOE distance constraints generated by the 








C-edited NOESY sub-spectra were used for the initial structure calculation. The 
distance upper bounds of the constraints were calibrated to three categories (2.8, 3.5, 
5.5 angstroms) according to the peak volumes. Dihedral angle constraints were 
generated by TALOS (Cornilescu, 1999), which empirically predicts the φ and ψ 






) of chemical 
 32
shifts for a given protein sequence. Only constraints that were classified as good 
prediction results were used for the structure calculation. Disulfide bond restraints 
were added only in the later stage, but not at the beginning. The initial structure 
calculation was done with DYANA (Herrmann et al., 2002), which started structure 
calculation from 50 conformers with random torsion angle values by simulated 
annealing with 10,000 steps per conformer. The software MOLMOL (Koradi, 1996) 
was used to display the structures. Energy minimization of the 5 conformers with the 
lowest target function values was selected. NOE peaks that gave distance violations 
>0.4 Å were checked and the range of angular constraints was set to two times of that 
predicted range by TALOS if specific dihedral angle violations were constantly larger 
than 5º. Initial structures were refined to minimize the violations. When a relatively 
good quality initial structure was acquired, ambiguous NOE peaks were then assigned 
according to the initial structure. Finally, 100 conformers with random torsion angle 
values by simulated annealing with 15,000 steps per conformer were calculated and 
the best 10 structures were selected for analysis.  
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Chapter 3 Results and Discussion 
3.1 Mdka construct  
Analysis of Mdka shows that the first twenty-three amino acids are highly 
hydrophobic, and alignment of Mdka and human MK indicates that these amino acids 
are the signaling peptide of this growth factor (Fig1.5). Therefore in the construct of 
Mdka for protein structure elucidation, the signal peptide was removed to get the 
mature protein directly. With signal peptide deleted, the final plasmid of Mdka in the 
vector of pGEX4T-1 was successfully constructed, which was used in the expression 
of Mdka with a GST fusion tag at the N terminal of the protein (Fig3.1).  
 
3.2 Expression and purification of Mdka  
3.2.1 Expression of GST-Mdka in E. coli  
Both labeled and unlabeled Mdka with a GST tag attached to the N terminal of 
the protein could be easily over-expressed by E. coli BL21 (DE3), although its 
expression was slightly lower in M9 medium than in LB medium. 2 L M9 culture was 
used to obtain a sample of 500 μl 1 mM double labeled Mdka. Since GST tag has a 
molecular weight of around 27 kDa and the molecular weight of Mdka is 13.5 kDa, 
GST tagged Mdka shows a molecular weight of around 40 kDa (Fig3.2A & B).  
 
3.2.2 Purification of Mdka  
After sonication, most of the protein was in supernatant (Fig3.2C). After 4 
times of washing, most of the unspecific bindings could be washed out except for a 
few impurities (Fig3.2D). The GST tag could be easily cleaved with 1 U thrombin 
cleaving about 1 mg protein within 1 hour. After GST beads purification, relatively 
pure protein was obtained, but it was not pure enough for NMR experiments until  
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Fig3.1 Final construct of Mdka. (A) Final amino acid sequence of the expressed 
Mdka in the E. coli expression system. (B) Amino acid components of Mdka.  
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Fig3.2 Mdka expression and purification by GST beads. (A) Expression in LB 
media. Lane 1: marker; Lane 2: pre-induction when the cell density reached OD600 
0.6, which was expression control; Lane 3: post-induction with 0.05 mM IPTG at 16 
°C for 12 hours, the GST-tagged Mdka shows a molecular weight of around 40 kDa. 
(B) Expression in M9 media. Lane 1: post-induction with 0.3 mM IPTG at 20 °C for 
20 hours; Lane 2: protein marker. (C) Solubility of Mdka. Lane 1: marker; Lane 2: 
pellets after sonication; Lane 3: supernatant after sonication. (D) GST purification. 
Lane 1: thrombin cleavage of Mdka for 3 hours (1 mg Mdka/ 1 U thrombin); Lane 2: 
thrombin cleavage of Mdka for 1 hour; Lane 3: marker; Lane 4: Mdka on GST beads 
after washing and before thrombin cleavage; Lane 5: the first time washing of Mdka 
with lysis buffer; Lane 6: the fourth time washing with lysis buffer; Lane 7: GST tag 
on GST beads after elution of Mdka from beads; Lane 8: the first time elution of 
Mdka from GST beads; Lane 9: the second time elution of Mdka from GST beads; 
Lane 10: the third time elution of Mdka from GST beads.  
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further purification of Mdka with a heparin affinity column (Fig3.3). 
 
3.3 General properties of Mdka  
Mdka is a small protein with a molecular weight of 13.5 kDa, which was 
verified by Q-TOF mass spectrum (Fig3.4). The theoretical molecular weight for 
Mdka is 13521.4 Da (Cys in reduced form; software ProtParam), thus if Cys residues 
are oxidized, the molecular weight should be 13511.4 Da. The Q-TOF mass spectrum 
shows that the molecular weight is 13510.6 Da, which indicates that the Cys residues 
of Mdka could be in the oxidized form. Besides, the CD spectrum profile (Fig3.5), 
especially the positive hump at the position of 230 nm, suggests that Mdka has a 
β-turn structure. The solubility of the protein could be as high as 1 mM as measured 
with UVA280. When the protein is concentrated to 1 mM, it is still in the monomer 
form as evidenced by the DLS result (Fig3.6). Furthermore, 1D NMR and 2D HSQC 
experiments demonstrate that the recombinant Mdka purified from E. coli in this way 
is well structured (Fig3.7). Mdka is also a stable protein that can stand 30 °C for one 
week (Fig3.7). Since during the heparin affinity column purification, high 
concentration of NaCl is needed to elute the protein out of the column, this suggests 
that the recombinant protein has strong binding affinity to heparin (Fig3.3A).  
 
3.4 Mdka in vivo assay: zebrafish embryonic development activity  
The activity of recombinant Mdka was tested in vivo using zebrafish embryo 
by our collaborator (Winkler, Dept of Biological Sciences, NUS). The recombinant 
Mdka was injected into zebrafish embryos, and the development of these embryos at 
different stages are compared with the wild type embryos as well as those injected 




volume (ml)  
 
Fig3.3 Heparin affinity column purification of Mdka. (A) Heparin column profile 
of Mdka. Mdka peak is indicated by Peak 2. (B) Peak fracture of Mdka from heparin 
affinity column. Lane 1: marker; Lane 2: from Peak 1; Lane3-7: from Peak 2. (C) 







Fig3.4 Q-TOF mass spectrum of Mdka. The protein was desalted and prepared in 







Fig3.5 CD spectrum of Mdka. Sample was prepared with 10 mM phosphate buffer 





Fig3.6 Apparent hydrodynamic MW of Mdka from DLS measurement. (A) Size 
distribution of Mdka protein particle in the buffer of 20 mM phosphate, 100 mM NaCl, 
pH 6.5, at 30 °C. The average size of Mdka protein is 2.02 nm. (B) Average molecular 
weight (MW) of Mdka. 20 MW values were analyzed, and the average MW is 13.7 
kDa with a standard deviation of 0.66 kDa.  
 41
  
Fig3.7 1D and 2D NMR experiments of Mdka. (A) 1D NMR spectrum was 
acquired on a 500 MHz NMR machine at 20 ºC in 20 mM Tris buffer, 100 mM NaCl, 
2 mM EDTA at pH 8.0. (B) Overlay of two sets of 2D 1H-15N HSQC spectra (magenta: 
acquired one week before, black: acquired one week later). The sample was stored at 
30 ºC for one week. Spectra were recorded at 800 MHz NMR at 30 ºC in 20 mM 
phosphate buffer, pH 6.5, 100 mM NaCl, 1 mM EDTA.  
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injected with recombinant Mdka show the same development phenotypes as 
RNA-injected embryos, which indicates that the recombinant protein is properly 
folded and has the proposed biological functions (Winkler, data not published).  
 
3.5 NMR assignment of Mdka  
3.5.1 Backbone assignment of Mdka  




N-edited NOESY and 3D 
CCH-TOCSY spectra, all the spin systems in the two domain regions of Mdka were 









N HSQC among the 125 amino acids of Mdka (with GS extension at the N 
terminal of the protein resulting from thrombin cleavage). Figure 3.8 is a part of the 





spectrum of assigned Mdka backbone peaks was shown in figure 3.10.  
 
3.5.2 Sidechain assignment of Mdka  
When backbone assignment was finished, the spin systems were identified, 
and therefore most of the sidechain chemical shifts were available. Some sidechain 




N-edited NOESY planes to 














C-edited NOESY. The assigned proton chemical shifts should be in 
consistent with the chemical shifts statistics of the twenty amino acids. The 
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 Fig3.8 Backbone connectivity of Mdka. (A) Cα connectivity for a stretch of residues 
from E39 to T41. (B) 4D 13C,15N-edited NOESY slices of E39, G40 and T41. Each 
1H-13C slice is labeled with proton identities with sequential connectivity information. 
15N and 1H frequencies in ppm with assigned residues are indicated at the top of each 
slice. (Labels are in the NMRView format.)  
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 B  
 
Fig3.9 Backbone assignment of Mdka. (A) Spin system identification. T41 was 
indentified because of its characteristic Cβ and Cγ chemical shifts. G40 was 
indentified according to its small Cα chemical shift and two HαCα peaks. G40 and T41 
form a fragment, and when comparing with the sequence of Mdka, there are only two 
GT fragments (EGT and TGT). Since E39 clearly is not Thr, thus, it could be 
identified to be Glu. (B) Assigned backbone peaks (magenta) and missing backbone 
peaks (black). (Labels are in the NMRView format.)  
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 Fig3.10 Assigned 1H-15N HSQC spectrum of Mdka backbone peaks. Spectrum 
was acquired at 800 MHz and 30 ºC on a sample of 0.8 mM protein and pH 6.5. The 
three Trp sidechain peaks are assigned. The labeled sequence numbers correspond to 
those in the final construct, and are consistent with NMRView format.  
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assignment of sidechain proton and carbon spins could further be verified by 1H-13C 
HSQC spectrum. Sidechain assignment for the loop regions was not as complete as 
the domain region. Totally, 78.3% aliphatic sidechain resonances were assigned. 
Aromatic sidechain assignment was also finished.  
 





 chemical shifts of an amino acid could be used as an 
indicator of the local secondary structure information, the secondary structure of 




 chemical shifts of each amino acid of 
Mdka with those of the random coil. The deviation ΔCα/ΔCβ equals the chemical shift 




 for an Mdka residue minus that for the same residue in a 
random coil structure. Positive secondary shift for C
α
 indicates that the secondary 
structure is helix, while negative result means that it is β-strand conformation. This 
trend is opposite in sign for C
β
 secondary shift. Thus ΔCα-ΔCβ could give an enhanced 
effect of the secondary structure information. Chemical shift index (CSI) of Mdka 
(Fig3.11) was obtained by plotting ΔCα-ΔCβ against the amino acid sequence. From 
the CSI, it can be inferred that the protein is mainly composed of β-sheets in the two 
domain regions, and there are three long loops at the two ends of the two domains as 
well as in-between.  
 
3.5.4 NOE assignment  
When the backbone and sidechain assignments were finished, most of the 












C-edited NOESY sub-spectra could be unambiguously assigned (Fig3.12). 
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Ambiguous NOE peaks were assigned based on the initial structure calculated with 





N-edited NOESY subspectrum where the C chemical shift could be 
converted into the N chemical shift with the equation: N (ppm) = (C-Cref)Csf/Nsf 
(ppm) + Nref (ppm) (Fig3.14C). Totally, there are 2085 NOE peaks: 926 intra-residual 
NOEs, 618 sequencial NOEs, 152 medium-range NOEs, and 389 long-range NOEs. 
As shown in the analysis of sequential- and medium-range NOEs (Fig3.13), strong 





i-1 and HNi were observed, which are consistent with the 
β-structure of Mdka. Successive strong long-range NOEs of HN-HC and HC-HC 
were observed, which are from the opposite strands of the antiparallel β-sheet.  
 
3.5.5 Structure calculation and refinement  
Initial structures calculated using the unambiguously assigned NOE peaks 
(distance constraints) and torsion angle constraints initially showed relatively large 
average target function. The main reason is because of the overlap of NOE peaks that 
results in larger peak volumes than they should be. After all the NOE peaks were 
assigned, 100 structures were calculated, and the best 10 structures show an average 
target function of 1.49. The N domain and C domain RMSD values between the 10 
conformers and the mean structures for the backbone heavy atoms are 0.76 and 1.65 
respectively. Each domain contains three anti-parallel β-sheets (Fig3.14). The 
distances between the C
β
 atoms of the two nearby Cys residues of the ten structures 
are shown in Table 1. As can be seen, except the pair of C75-C107 and C65-C97, all 
the Cys pairs show distances of the C
β
 atoms between 3 Å to 8 Å. The C65-C97 




protons have NOEs with  
 48
  
Fig3.11 Chemical shift index of Mdka. ΔCα/ΔCβ equals Cα/Cβ of Mdka amino acid 
minus that of the same amino acid in a random coil structure.  
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Fig3.12 NOE assignment. (A) Representative slices of HN-HC assignment from the 
4D 13C,15N-edited NOESY subspectrum. (B) HC-HC NOE assignment from the 4D 
13C,13C-edited NOESY subspectrum. (C) HN-HN assignment from the 4D 
15N,15N-edited NOESY subspectrum. The C chemical shifts and N chemical shifts can 
be transferred using the equation of Ncs = (Ccs-Cref)Csf/Nsf+Nref (Labels are in the 





Fig3.13 Sequential- and medium-range NOE pattern of Mdka. The NOE 
intensities are represented by the thickness of the solid bars.  
 51
L88 HδCδ proton. C75-C107 pair shows relatively larger distances than the other pairs, 
ranging from 7.3 Å to 12.3 Å. 
 
3.5.6 Disulfide restraints determination  




 of any Cys residues 
observed, the ten Cys residues in Mdka should form five pairs of disulfide bonds, 
which was determined empirically and experimentally. The sequence alignment of the 
Midkine family shows that the Cys residues are highly conserved among the family 
(Fig1.5), and Mdka has sequence identity as high as 58% with human MK. Thus it is 
expected that the overall structure of the two proteins would be more or less the same, 
which indicates that the disulfide linkage of the two proteins would be identical. 
Therefore the five pairs of the disulfide bridge should be: C18-C42, C26-C51, 
C33-C55, C65-C97, and C75-C107 according to the sequence of Mdka construct in 
this study. In addition, Q-TOF mass spectrum shows that the molecular weight of the 
recombinant Mdka is 13510.6 Da. Theoretically, the molecular weight of Mdka is 
13511.4 Da if five pairs of disulfide bond are formed, and 13521.4 Da if not (software 
ProtParam). This suggests that there are five pairs of disulfide bridges in the 
recombinant Mdka protein. Besides, NMR analysis shows that the C
β
 chemical shifts 
of all Cys in the protein sequence are larger than 30 ppm, which also indicates 
disulfide bonds formation (Sharma and Rajarathnam, 2000). Moreover, the initial 
structure of Mdka shows that the distances between the C
β
 atoms of the Cys pairs are 
all around 3.5 Å to 8 Å (C75-C107 within 7.3 Å to 12.3 Å ), which is near enough to 
form disulfide bonds. Therefore, structures with disulfide constraints were calculated. 
The target function of the structures calculated with these five pairs of disulfide 
constraints is similar with that calculated without. Therefore, although there is no  
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Fig3.14 Comparison of Mdka domain structures calculated with and without 
disulfide constraints. (A) Initial Mdka domain structures without disulfide 
constraints. Cys residues are colored in blue. (B) Mdka domain structures calculated 

















NOE observed among the ten Cys residues, it can be concluded that 
the disulfide bonds should be formed in this way. 
 
3.6 NMR structure of Mdka  
The final structure of Mdka was calculated with distance constraints, dihedral 
angle constraints, hydrogen bond constraints, and disulfide bond constraints. The final 
structural statistics are listed in Table 2. G1-D17 is the N terminal loop; C18-C55 
forms the N domain; N56-D64 is the liker between the two domains; C65-C107 is the 
C domain; and T108 to the end is the C terminal tail. Since there is no confirmed 
interaction observed among the three loops and the two domains, these parts are 
supposed to be able to move freely from each other (Fig3.15). The RMSD between 
the 10 conformers and the mean structures are 0.56 Å (L21-C55) and 0.54 Å 
(Y67-C107, excluding the long loop) for backbone heavy atoms, and 1.12 Å 
(L21-C55) and 0.82 Å (Y67-C107, excluding the long loop) for all non-hydrogen 
atoms in the well-defined regions, respectively.  
N domain (C18-C55) consists of three antiparallel β-sheets, βN1 (L22-A28), 
βN2 (G36-C42), βN3 (T46-V53), which are connected by two loops. C domain 
(C65-C107) also consists of three antiparallel β sheets: βC1 (W67-D76), βC2 
(T81-Q87), βC3 (T100-K105). There are also two loops connecting these three β 
strands, but the loop between βC1 and βC2 is longer than the others.  
All the three proline residues are in the trans configuration as evidenced by 








 of the preceding 
residues (Fig3.17). Hydrophobic, charged, and other polar residues are colored on the 
space filling model of Mdka (Fig3.15). Given that Mdka is highly basic charged, and 
it has strong binding ability to the negative charged heparin molecule, the basic  
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Table 2 Structural statistics of Mdkaa  
 
a10 energy-minimized 10 structures were investigated. bDihedral angle constraints 
were generated by TALOS. cHydrogen bonds were identified on the basis of NH-D2O 
exchange experiment. Two constraints per hydrogen bond (dHN-O ≤ 2.2 Å and dN-O ≤ 
3.2 Å) were included in the final structure calculations by visual inspection of 
preliminary structures derived from the NOE data. dPROCHECK-NMR was used to 
assess the quality of the structures.  
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Mdka N domain  
 
Mdka C domain  
 
Fig3.15 Solution structure of Mdka. (A/E) Superposition of the backbone heavy 
atoms of the 10 best calculated Mdka structures. The Mdka conformers are fitted for 
minimal RMSD of the backbone atoms of all residues in both domains. (B/F) Ribbon 
drawing of the best conformer of Mdka. (C/G) Space filling model of Mdka domains 
with annotations of basic (blue), acidic (red), hydrophobic (pink), and polar (purple) 
residues on the surface. (D/H) Back view of C/G. (I) Ribbon model of the best 
conformer of the whole protein.  
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 Fig3.16 Ramachandran plot of Mdka.  
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 Fig3.17 Configuration of proline residues. 4D 13C,13C-edited NOESY subspectra 




residues in the two domains of Mdka colored in blue seem to form clusters and could 
be the possible binding sites for heparin. 
 
3.7 Structural comparison to other Midkine family members  
3.7.1 Structure comparison of Mdka and human MK  
The three dimensional domain structures of Mdka were compared with those 
of human MK. The N domain backbone architectures of the two proteins are 
relatively similar, but C domains have larger differences (Fig3.18). The loop between 
βC2 and βC3 in human MK is bent towards the three β sheets because NOEs are 
detected among them. In Mdka no such NOE is observed, and the position of the βC1 
seems to prevent the long loop from bending over. The linear sequence alignment of 
the two proteins shows an overall amino acid identity of 58% (Fig1.5), with 57% and 
65% identity for the N domain and C domain respectively. The conserved residues as 
well as non-conserved ones are colored on the transparent surface diagram of Mdka, 
where a cluster of non-conserved residues is found on one side in the C domain of 
Mdka (Fig3.19 C). These residues might be responsible for the different functions 
between Mdka and human MK. In contrast, a cluster of identical residues is found on 
the opposite side in the C domain, where basic residues cluster together (Fig3.22 D), 
which might form the heparin binding site of Mdka.  
In addition, there are some similarities between the structures of Mdka and 
human MK. Both the N domain and C domain of MK display a β-bulge-like structure 
because of Pro22 in the N domain and Asn68-Trp69-Gly70 fragment in the C domain. 
While the corresponding position of MK Pro22 is changed to Ser25 in Mdka, yet the 
bulge is still there. The twist in the βN1 (L22-A28) of both proteins is also similar. 




Fig3.18 Comparison of Mdka with human MK. (A/D) N/C domain backbone 
superimposition of Mdka (cyan) and MK (magenta). (B/E) Ribbon diagram of Mdka 
N domain and C domain. (C/F) Ribbon diagram of human MK N domain and C 
domain. [Human MK structure is from PDB file 1mkc and 1mkn. Ribbon structures 
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Fig3.19 Sequence comparison of Mdka and human MK. (A) Sequence alignment 
of N domain and C domain of Mdka and human MK. {Note: red: small [small + 
hydrophobic (incl.aromatic -Y)], blue: acidic, magenta: basic, green: hydroxyl + 
amine + basic – Q; "*" means that the residues in that column are identical in all 
sequences in the alignment; ":" means that conserved substitutions have been 
observed, according to the color table available at http://www.ebi.ac.uk/Tools 
/clustalw2/scorestable_frame.html; "." means that semi-conserved substitutions are 
observed.} (B) N domain (C) C domain of Mdka represented by the transparent 
surface diagram with the ribbon digram beneath it. Residues are colored according to 
the above sequence alignment result. (Note: blue: identical residues; yellow: 
conserved substitutions have been observed in human MK; orange: semi-conserved 
substitutions are observed in human MK; red: non-conserved residues; green: 




Sequence homology that is observed in human MK between the βN2 
(Arg35-Glu36-Gly37-Thr38) and βC2 (Arg81-Gln82-Gly83-Thr84) as well as βN3 
(Ile46-Arg47, Pro51-Cys52) and βC3 (Ile98-Arg99, Pro103-Cys104) is not found in 
Mdka. Instead, a homology is found between the N terminal loop 
(Gly15-Ala16-Asp17 -Cys18) and the end of the linker (Gly62-Ala63-Asp64-Cys65). 
But we have no idea about whether the existence of these repetitive fragments in this 
growth factor family is a coincidence or results from evolution.  
The C domain heparin binding site of MK was mapped using NMR 
perturbation by adding heparin 12mer solution. Iwasaki et al. discovered that K79 
(βC2), R81 (βC2), and K102 (βC3) from the C domain β-sheets as well as K86, K87, 
and R89 from the long loop between βC2 and βC3 are the key residues involving in 
heparin binding. The corresponding six residues in Mdka are: K82 (βC2), R84 (βC2), 
K105 (βC3), Q89, K90, and L92. Therefore, the three charged residues on the 
β-sheets are very likely to be involved in heparin binding, but whether residues from 
the long loop participate in this activity needs further validation.  
Moreover, the stoichiometry of MK-heparin oligosaccharide complex was 
investigated by laser light scattering experiments, and it was reported that MK formed 
a dimmer upon binding to heparin of >20 monosaccharide units. Kojima et al. also 
reported the property of MK dimmerization, and three glutamine residues, although 
not conserved among species through evolution, had been identified to be responsible 
for the transglutaminase-mediated dimer formation of MK. Among the three residues, 
two are conserved in Mdka (Q45 and Q98), and one is changed to R47. The two 
glutamine residues are not far away from the non-conserved residues (Fig3.19 B & C). 
So far we have no idea whether Mdka would dimerize when it binds to heparin.  
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 3.7.2 Structure comparison of Mdka with human PTN  
The structure of E.coli-expressed human PTN was analyzed by NMR 
(Kilpeläinen et al., 2000; Fig3.19 & Fig3.20), and its heparin binding activity was 
also investigated. Although no three dimensional structure of PTN is found in PDB, 
its secondary structure could be compared with that of Mdka. The main difference lies 
in the N domain, which has amino acid identity of 47%; the loop connecting βN2 and 
βN3 is longer in PTN than Mdka. The C domains of the two proteins are highly 
conserved with sequence identity as high as 60%. Similar features of the two proteins 
include the antiparallel β-sheet structures of the two domains, a highly conserved 
linker region, and the Lys-rich N-terminal and C-terminal tails.  
The heparin binding activity of PTN was analyzed using NMR and heparin 
affinity chromatography. The results show that both the N- and C-β-sheet domains 
bind to heparin in solution. NMR results also suggest that the Lys-rich tails, though 
highly charged, do not contribute to the binding of PTN to heparin and remain 
unstructured in the PTN-heparin complex. Upon binding to heparin, PTN undergoes 
structure changes according to the CD spectroscopy, especially prominent at 
wavelengths of 200 and 230 nm. However, how the structure changed is still unknown. 
Since human MK could form a dimmer when binding to heparin, the CD spectrum 
profile changes of PTN might be due to the dimmerization as well. The disulfide 
bonds in PTN are essential to maintain the native structure since reduction of disulfide 
bonds dramatically reduced heparin binding. Therefore, it can be inferred that 
disulfide bonds in Mdka play pivotal role to the formation of the β-sheet structure. 
Heparin binding activity of Mdka might also be due to the β-sheet domain structure 
rather than the charged N-terminal and C-terminal tails.  
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 Fig3.20 Sequence alignment of Mdka and PTN. β sheets of PTN were shown as 
white arrows (Kadomatsu and Muramatsu, 2004). {Note: red: small [small + 
hydrophobic (incl.aromatic -Y)], blue: acidic, magenta: basic, green: hydroxyl + 
amine + basic – Q; "*" means that the residues in that column are identical in all 
sequences in the alignment; ":" means that conserved substitutions have been 
observed, according to the colour table available at http://www.ebi.ac.uk/Tools 
/clustalw2/scorestable_frame.html; "." means that semi-conserved substitutions are 
observed.} (Software ClustalW2, EBI, ExPASy).  
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Fig3.21 Secondary structure of PTN. Curved arrows show the location of disulfide 
bonds. Straight arrows indicate long-range NOE interactions (Kilpeläinen et al., 
2000).  
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3.7.3 Comparison of Mdka with Mdkb  
The linear sequence alignments of the two domains of Mdka and Mdkb 
suggest that the sequence identity of the two proteins is very high, with 71% and 69% 
identity for the N domain and C domain respectively. Thus the three dimensional 
structures of the two proteins might be of high similarity. Residues that are conserved 
between the two proteins as well as those have substitutions are colored according to 
the sequence alignment result (Fig3.22). One conserved glutamine residue, which is 
involved in the dimerization of MK, is in the vicinity of the non-conserved residue in 
the C domain of Mdka (Fig3.22 D). From the sequence comparison, nine basic 
residues are identified in the C domain of Mdkb, among which six are conserved in 
Mdka and the other three are substituted by neutral amino acids in Mdka. These nine 
basic residues form two basic clusters, and might be the heparin binding site of Mdkb. 
In contrary to C domain, one basic residue in the N domain of Mdkb has changed to a 
neural one. Therefore, the functional difference of Mdka and Mdkb might lie in the 
fact that the charges of the C domains of the two proteins are different. Since Midkine 
family could bind to the transmembrane heparan sulfate proteoglycans to induce 
intracellular signaling pathways, the charge difference of the C domains of Mdka and 
Mdkb might possibly lead them to bind to different kinds of transmembrane receptors, 
thus inducing different signaling pathways.  
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Fig3.22 Sequence comparison of Mdka and Mdkb. (A) Sequence alignment of N 
domain and C domain of Mdka and Mdkb. (Note: residues are colored in the same 
way as in Fig3.20) (B) N domain (C) C domain of Mdka represented by the 
transparent surface diagram with the ribbon diagram beneath it. Residues are colored 
according to the above sequence alignment result. (Note: residues are colored in the 
same way as in Fig3.20.) (D) Basic residues in the sequence of Mdkb are colored 
accordingly in the C domain of Mdka. Hot pink: residues conserved between Mdka 
and Mdkb. Purple: basic residues in Mdkb that are substituted by neural ones in Mdka. 
Green: glutamine residue that might mediate dimerization in Mdka and Mdkb.  
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Chapter 4 Conclusion and Future Work  
 
Recombinant Mdka is expressed as a well structured soluble protein using E. 
coli BL21 (DE3) strain, and is suitable for NMR study. It has the same disulfide 
linkage pattern as human MK and PTN. As a heparin binding growth factor, it shows 
strong binding to heparin in vitro. Zebrafish embryos after injection of the E. 
coli-expressed Mdka show the same development phenotypes as those injected with 
in-vitro-synthesized RNA, which means that the recombinant protein is properly 
folded and has the desired biological functions. The solubility of Mdka is quite high; 
when it is concentrated to 1 mM, the protein still exists in monomer form. Besides, it 
is also a stable protein that can stand 30 °C for one week. All these properties of Mdka 
make it suitable for structure elucidation by NMR. Moreover, sequence alignment of 
Mdka with human MK reveals many long loops present in Mdka, which suggests that 
it would be extremely difficult to crystallize the protein. Thus, NMR becomes the 
only way to solve the structure of this protein.  
In this study, the solution structure of recombinant Mdka is determined based 
on the multidimentional NMR using a novel backbone assignment method developed 
by our group. The 4D NMR method is originally designed for structure elucidation of 
larger proteins (~40-50 kDa), this work shows that this method can also be used to 
solve high resolution structures for small proteins despite the fact that the 4D NMR 
method may lose some peak intensity. The structure of Mdka shows that there are two 
long tails and two domains. Connecting the two domains is a linker with amino acids 
highly conserved among the MK family. We are not sure whether the linker has 
specific functions, and it seems that the linker is also flexible. Each domain is 
composed of three antiparallel β sheets, resembling that of human MK. Comparing 
 69
individual domains of Mdka with human MK indicates that the N domain backbone 
architectures of the two proteins are more or less the same; while C domains show 
larger differences between the two proteins, especially for the position of the long 
loop between βC2 and βC3. In human MK, this long flexible loop is bent towards the 
three β sheets. In Mdka, the position of the βC1 seems to prevent the long loop from 
bending over. Therefore, the C domain of human MK has a more globular shape, 
while the C domain of Mdka seems more flat.  
By comparing Mdka with other members of the MK family, we can infer that 
C domain of Mdka might contribute to most of the heparin binding activity. The 
highly positive charged N terminal and C terminal tails might not be involved in 
heparin binding. Instead, charged residues on the C domain could be the possible 
heparin binding sites. Besides, Mdka could possibly form a dimer upon binding to 
heparin.  
With the structure of Mdka available, future work can be carried on in the 
following directions. First of all, to understand why the two Midkine proteins in 
zebrafish, Mdka and Mdkb, have different expression and functional patterns, the 
structures of the two proteins can be compared (Lim Jack Wee in our group is 
currently solving the structure of Mdkb). Since the sequence alignment of the two 
proteins shows that the domain regions have high sequence identity (70%), it is very 
likely the two proteins have similar structural architecture. If the structure is similar, 
then it would be interesting to pursue the reason why similar protein structures can 
lead to different functions. Of interesting notice is that there is charge difference 
between the C domains of the two proteins; Mdkb has three more basic residues than 
Mdka does in the possible heparin binding site. This charge difference might possibly 
be the reason why Mdka and Mdkb perform differently during zebrafish 
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embryogenesis.  
Besides, the heparin binding sites of Mdka need to be identified to understand 
where the key residues are that directly involve in the functions of this protein. 
Methods such as titration of heparin to Mdka, NMR perturbation, and site-directed 
mutagenesis of Mdka in binding with heparin can be used to pursue this target. Since 
Mdka has neural development function as well as heparin binding activity, it is 
possible that these two functions are performed via two different binding sites. Since 
the C domain of human MK is well studied and it is believed to be essential for 
heparin binding activity, the same situation might also be applied to the C domain of 
zebrafish Mdka. Therefore, charged residues on the Mdka C domain might be the 
candidates to do mutagenesis analysis to map the binding sites to heparin. Yet the N 
domain function of this family is still unclear. Whether the N domain is responsible 
for the neural development activity needs further validation.  
In addition, if possible, the binding complex of Mdka to its partner can be 
analyzed to get a view of the complex structure. So far the most commonly used 
ligand to evaluate the activity of MK family is heparin. Native heparin is a polymer 
with a molecular weight ranging from 3 kDa to 40 kDa, although the average 
molecular weight of most commercial heparin preparations is in the range of 12 kDa 
to 15 kDa. Iwasaki et al. found that heparin of >20 monosaccharide units would 
induce MK dimerization, and Kaneda (1996b) et al. reported that the minimize size 
for heparin to inhibit MK from binding to neurons is approximately 22 
monosaccharide units (7 kDa). Complex structure would provide answers to questions 
such as how the dimer is fomed, how the two domains are orientated when binding to 
the ligand, and what the position of the linker and the terminal tails are.  
Moreover, to fully understand how the two zebrafish Midkines function, why 
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two proteins are needed in zebrafish while in the higher vertebrates only one homolog 
is present, and what the factors are to differentiate these two proteins, the signaling 
pathways of the two growth factors involved should be studied before these questions 
can be answered.  
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